Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AUDIENCEX and AlMashtal Form Strategic Alliance, Launch AUDIENCEX KSA
-
CloudMD Announces Go-Private Transaction with CPS Capital
-
Safe and Green Development Corporation Reports First Quarter 2024 Financial Results and Provides a Business Update
-
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
-
Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities
-
Oatly Group AB Announces Results of 2024 Annual General Meeting
-
Thurgood Marshall College Fund added Denmark Technical College to its membership
-
AITX Announces Its Breakthrough AIR™ (Autonomous Intelligent Response) Technology
-
Invesco Ltd: Form 8.3 - International Paper Company
-
ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
-
Kartoon Studios Continues Execution of Growth Strategy With Profitability Targeted for Q2 2025; Provides Business Update for the First Quarter of 2024
-
ARHT's Multi-Panel Holographic Display Brings to Life British Artist Allen Jones' Art in France
-
Airship AI Reports First Quarter 2024 Financial Results
-
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Conference
-
Yield10 Bioscience Announces Delisting from Nasdaq
-
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
-
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
-
Sow Good Reports Strong First Quarter 2024 Results
-
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
-
Zhibao Technology Inc. Announces Closing of Underwriters’ Over-Allotment Option in Connection with Its Initial Public Offering
-
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
-
BOSS Money Customers Sent Cash Home to Mom at a Record Rate
-
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the First Quarter Ended March 31, 2024
-
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
-
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double Company’s Revenue
-
ALERUS FINANCIAL CORPORATION AND HMN FINANCIAL, INC. JOINTLY ANNOUNCE STRATEGIC TRANSACTION
-
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
-
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
-
Sienna Announces May Dividend
-
Genasys Receives $2.7 Million U.S. Navy Order for LRAD Maritime Systems
-
Leaders in Data Strategy Gather at Qlik Connect 2024 to Showcase AI Innovation and Results
-
Verkkokauppa.com’s Capital Markets Day on 30 May 2024
-
Invesco Ltd: Form 8.3 - BHP Group Ltd
-
Invesco Ltd: Form 8.3 - Anglo American PLC
-
Workers at Coven Market join SEIU Local 2; Business owner proud of employees and looks forward to productive relationship
-
FTC Solar Announces New Sales and Leadership Appointments
-
Progressive Reports April 2024 Results
-
Alliance Trust PLC - Net Asset Value
-
NordVPN joins efforts to develop anti-malware and VPN testing
-
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
-
U.S. Tariff Policy Changes to Benefit American Rare Earths Ltd.
-
Mitsubishi HC Capital America and Electrada Partner to Provide EV Charging-as-a-Service for Vehicle OEMs and Commercial Customers
-
The Doggone Foundation donates $150K to the MUHC Foundation to support breast cancer research
-
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis
-
Glassdoor Names USI Insurance Services Among the ‘Best-Led Companies’ in the US
-
Lifeward Reports First Quarter 2024 Financial Results
-
Snail, Inc. to Report First Quarter 2024 Financial Results
-
BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
-
CAPREIT Announces May 2024 Distribution

